DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Wang Y, Lou Y, Wang J. et al.
Design, synthesis and biological evaluation of 6-deoxy O-spiroketal C-arylglucosides as novel renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Eur J Med Chem 2019;
180: 398-416
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.